Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.
Sivapalan P, Ulrik CS, Lapperre TS, Bojesen RD, Eklöf J, Browatzki A, Wilcke JT, Gottlieb V, Håkansson KEJ, Tidemandsen C, Tupper O, Meteran H, Bergsøe C, Brøndum E, Bødtger U, Bech Rasmussen D, Graff Jensen S, Pedersen L, Jordan A, Priemé H, Søborg C, Steffensen IE, Høgsberg D, Klausen TW, Frydland MS, Lange P, Sverrild A, Ghanizada M, Knop FK, Biering-Sørensen T, Lundgren JD, Jensen JS; ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group.
Sivapalan P, et al. Among authors: hakansson kej.
Eur Respir J. 2022 Jan 6;59(1):2100752. doi: 10.1183/13993003.00752-2021. Print 2022 Jan.
Eur Respir J. 2022.
PMID: 34083403
Free PMC article.
Clinical Trial.